STOCK TITAN

Myriad Genetics Names Pamela Wong as Chief Legal Officer

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Myriad Genetics announced the appointment of Pamela Wong as the new Chief Legal Officer, effective October 18, 2021. Wong, bringing over 20 years of experience in healthcare and legal sectors, will oversee legal functions including intellectual property, litigation, and regulatory compliance. Her previous roles include serving as Assistant General Counsel at Quest Diagnostics and an intellectual property partner at Baker-McKenzie. CEO Paul J. Diaz praised her expertise, stating she will significantly contribute to the company’s legal strategy and growth initiatives.

Positive
  • Pamela Wong brings over 20 years of legal and healthcare expertise.
  • Previous experience includes 14 years at Quest Diagnostics and 8 years at Baker-McKenzie.
  • Wong's leadership expected to enhance the company's legal strategy and operational excellence.
Negative
  • None.

New legal leader brings healthcare expertise from Quest Diagnostics and experience at major global law firms

SALT LAKE CITY, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of Pamela Wong as its new Chief Legal Officer. In her role, she is responsible for leading the company’s legal function, including support and counsel for all legal affairs, intellectual property, patent protection, mergers and acquisitions, litigation, regulatory and quality assurance, compliance, and government affairs.

As a legal executive and business leader with deep healthcare and legal expertise, Wong brings more than twenty years of experience spanning global IP portfolio development, management and enforcement, risk mitigation and negotiating complex commercial licensing agreements. She will report directly to Paul J. Diaz, president and CEO of Myriad Genetics.

Prior to joining Myriad Genetics, Wong spent 14 years with Quest Diagnostics, most recently as its Assistant General Counsel. Prior to Quest, she worked eight years at Baker-McKenzie where she was an intellectual property partner, and at Pillsbury Winthrop Shaw Pittman LLP.

“Pamela is an accomplished legal leader with wide-ranging and relevant expertise deeply rooted in the healthcare industry. She brings a proven ability to effectively manage complex legal and business issues,” said Diaz. “As we continue our transformation and growth plan, she will play an instrumental role in steering our legal strategy with integrity, operational excellence and legal pragmatism. We are fortunate to have a talented legal professional of her caliber as the latest addition to the Myriad Genetics executive team.”

Wong holds a B.S. degree from the University of California-Berkeley, a Ph.D. from Florida State University-Tallahassee and a J.D. from the University of San Diego.

About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and wellbeing for all, empowering individuals with vital genetic insights and enabling healthcare providers to better detect, treat and prevent disease. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit the Company's website: www.myriad.com.

Myriad, the Myriad logo, BART, BRACAnalysis, Colaris, Colaris AP, myRisk, Myriad myRisk, myRisk Hereditary Cancer, myChoice, myPlan, BRACAnalysis CDx, Tumor BRACAnalysis CDx, myChoice CDx, EndoPredict, Prequel, Foresight, GeneSight, riskScore and Prolaris are trademarks or registered trademarks of Myriad Genetics, Inc. or its wholly owned subsidiaries in the United States and foreign countries.

Media Contact:Investor Contact:
Megan ManzariNathan Smith
(801) 505-5027(801) 505-5067
Megan.Manzari@myriad.comNathan.Smith@myriad.com


FAQ

Who is the new Chief Legal Officer at Myriad Genetics?

Pamela Wong has been appointed as the new Chief Legal Officer at Myriad Genetics.

What experience does Pamela Wong bring to Myriad Genetics?

Pamela Wong brings over 20 years of experience in healthcare legal matters, including roles at Quest Diagnostics and global law firms.

When was Pamela Wong appointed as Chief Legal Officer at Myriad Genetics?

Pamela Wong was appointed Chief Legal Officer on October 18, 2021.

What responsibilities will Pamela Wong have at Myriad Genetics?

Pamela Wong will oversee legal affairs, intellectual property, compliance, and regulatory matters at Myriad Genetics.

Who made the announcement regarding Pamela Wong's appointment at Myriad Genetics?

The announcement was made by Paul J. Diaz, the President and CEO of Myriad Genetics.

Myriad Genetics Inc

NASDAQ:MYGN

MYGN Rankings

MYGN Latest News

MYGN Stock Data

1.37B
88.81M
2.02%
102.23%
4.94%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States of America
SALT LAKE CITY